Latest Articles

Publication Date
Stacey Rusch Supports Wendy Osefo Through Legal Ordeal - Urban Woman Magazine

Stacey Rusch Supports Wendy Osefo Through Legal Ordeal Urban Woman Magazine

Published: Oct. 25, 2025, 4:03 p.m.
Love Is Blind Star Madison Maidenberg Embraces Single Status and New Beginnings - Urban Woman Magazine

Love Is Blind Star Madison Maidenberg Embraces Single Status and New Beginnings Urban Woman Magazine

Published: Oct. 25, 2025, 11 a.m.
The new face of endometriosis care in Nigeria - primeprogressng.com

The new face of endometriosis care in Nigeria primeprogressng.com

Published: Oct. 23, 2025, 4:07 p.m.
‘It’s time to stop ignoring the impact of endometriosis in the workplace’ - People Management

‘It’s time to stop ignoring the impact of endometriosis in the workplace’ People Management

Published: Oct. 23, 2025, 12:26 p.m.
No issues found with popular hormone replacement patches: Ministry of Health - RNZ

No issues found with popular hormone replacement patches: Ministry of Health RNZ

Published: Oct. 23, 2025, 3:47 a.m.
Targeting Steroid Receptor Coactivators for the Treatment of Benign Female Reproductive Disorders.

Steroid receptor coactivators (SRCs) are master regulators of nuclear receptor signaling and play essential roles in female reproductive physiology. By integrating steroid hormone signaling with growth factors and metabolic pathways, …

Published: Oct. 23, 2025, midnight
Kissei Pharmaceutical Expands Linzagolix Reach with Canadian Licensing Deal - MSN

Kissei Pharmaceutical Expands Linzagolix Reach with Canadian Licensing Deal MSN

Published: Oct. 21, 2025, 5:24 p.m.
Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - BioSpace

Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer BioSpace

Published: Oct. 21, 2025, 5:15 a.m.
Cyclana Bio Raises £5M to Reverse Endometriosis Through Extracellular Matrix Targeting - Femtech Insider

Cyclana Bio Raises £5M to Reverse Endometriosis Through Extracellular Matrix Targeting Femtech Insider

Published: Oct. 20, 2025, 8:02 a.m.
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - BioSpace

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer BioSpace

Published: Oct. 20, 2025, 4:42 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!